Search

Hauser, RA, KE Lyons, and R Pahwa. 2012. “The UPDRS-8: A Brief Clinical Assessment Scale for Parkinson’s Disease. Int J Neurosci 2012;122:333-7.”. Int J Neurosci.

Tetrud, J, P Nausieda, D Kreitzman, GS Liang, A Nieves, AP Duker, RA Hauser, et al. 2017. “Conversion to Carbidopa and Levodopa Extended-Release (IPX066) Followed by Its Extended Use in Patients Previously Taking Controlled-Release Carbidopa-Levodopa for Advanced Parkinson’s Disease. J Neurol Sci 2017;373:116-123.”. J Neurol Sci.

Hauser, RA, SA Factor, SR Marder, MA Knesevich, PM Ramirez, , J Burke, GS Liang, and CF O’Brien. 2017. “KINECT 3: A Phase 3 Randomized, Double-Blind, Placebo-Controlled Trial of Valbenazine for Tardive Dyskinesia. Am J Psychiatry 2017;174:476-484.”. Am J Psychiatry.

Olanow, CW, K Kieburtz, M Leinonen, N Giladi, RA Hauser, OS Klepiskaya, DL Kreitzman, et al. 2017. “A Randomized Trial of a Low-Dose Rasagiline and Pramipexole Combination (P2B001) in Early Parkinson’s Disease. Mov Disord 2017;32:783-789.”. Mov Disord.

Fernandez, HH, SA Factor, RA Hauser, J Jimenez-Shahed, and . 2017. “Randomized Controlled Trial of Deutetrabenazine for Tardive Dyskinesia: The ARM-TD Study. Neurology 2017;88:2003-2010.”. Neurology.

LeWitt, PA, RA Hauser, DG Grosset, F Stocchi, MH Saint-Hilaire, A Ellenbogen, M Leinonen, et al. 2016. “A Randomized Trial of Inhaled Levodopa (CVT-301) for Motor Fluctuations in Parkinson’s Disease. Mov Disord 2016;31:1356-65.”. Mov Disord.

Weintraub, D, RA Hauser, V Abler, E Eyal, and RE Eliaz. 2016. “Rasagiline for Mild Cognitive Impairment in Parkinson’s Disease: A Placebo-Controlled Trial. Mov Disord 2016;31:709-14.”. Mov Disord.

Investigators, Huntington Study Group PHAROS. 2016. “Clinical-Genetic Associations in the Prospective Huntington at Risk Observational Study (PHAROS): Implications for Clinical Trials. JAMA Neurol 2016;73:102-110.”. JAMA Neurol.

Stegemoller, EL, P Schmidt, , and National Parkinson Foundation Quality Improvement Initiative Investigators. 2015. “How Should Pushing Off or the Use of Assistive Devices Be Incorporated in the Timed Up and Go for Persons With Parkinson Disease? Arch Phys Med Rehabil 2015;96:1728-32.”. Arch Phys Med Rehabil.

Investigators, FS-ZONE. 2015. “Pioglitazone in Early Parkinson’s Disease: A Phase 2, Multicentre, Double-Blind, Randomised Trial. NINDS Exploratory Trials in Parkinson Disease (NET-PD). Lancet Neurol 2015;14:795-803.”. Lancet Neurol.